LABETALOL hydrochloride, 200mg, tab.

STD DORALABE2T-

Valid Article

Former Code(s): -X

Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C07AG01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.

OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

https://www.unicat.msf.org/web/image/product.template/572516/image_1920?unique=6ebdfeb

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

LABETALOL

Therapeutic Action

Non cardioselective beta-blocker

Indications

Gestational and chronic hypertension in pregnant women

Instructions for use

Both dosages (100 and 200 mg) must be ordered to allow initiation and adjustment of the dose, as the 200 mg tablet is not breakable.

Labetalol is considered as the first-line treatment for hypertension in pregnancy, with Nifedipine as the second alternative and methyldopa as the third due to more side effects and lower effectiveness. Contact you SRH advisor to determine the best option for your program and context.

Storage

Below 25°C ‐ Protect from sunlight ‐ Protect from humidity